Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThird Poi. $ Regulatory News (TPOU)

  • This share is currently suspended. It was suspended at a price of 20.30
  • There is currently no data for TPOU

Kepler Trust Intelligence: New Research

1 Oct 2020 08:00

RNS Number : 6931A
Third Point Investors Limited
01 October 2020
 

Third Point Investors: New research

01/10/2020

TPOU's portfolio has been pivoted year to date, and with renewed focus from board and manager, the discount of 23% looks anomalous…

The investment companies team at Kepler Trust Intelligence has produced a new piece of investment bank quality research about the trust, designed to provide a clear and comprehensive reference for long term investors. This note is free to read for UK investors.

Click here to read the note in full.

 

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

 

 

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 9/10 Savile Row, London W1S 3PF with registered number OC334771.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Private Policy.
 
END
 
 
NRAEAENEDFPEEAA
Date   Source Headline
10th Sep 20257:30 amRNSSuspension - Third Point Investors Limited
8th Sep 20254:39 pmPRNDirectorate Change
8th Sep 202511:32 amPRNPublication of Prospectus
5th Sep 20257:00 amPRNMonthly Update: August 2025 NAV Performance
4th Sep 20252:00 pmRNSRuling Hearings Comm - Third Point Investors Ltd
4th Sep 202512:28 pmPRNResults of the Redemption Offer and Subscriptions, Update on the acquisition of Malibu Life Reinsurance SPC and Update on the timetable for implementation of the Proposals
4th Sep 20257:00 amPRNMonthly Estimate Net Asset Value - August 2025
29th Aug 20254:02 pmPRNWeekly Estimate Net Asset Value - August 2025
28th Aug 20255:02 pmPRNMonthly Final Net Asset Value - July 2025
22nd Aug 20255:02 pmPRNWeekly Estimate Net Asset Value - August 2025
15th Aug 20254:50 pmPRNTermination of Broker Appointment
15th Aug 20252:40 pmPRNWeekly Estimate Net Asset Value - August 2025
14th Aug 20253:45 pmPRNDirectorate Change
14th Aug 20251:07 pmPRNResult of Annual General Meeting
14th Aug 202512:57 pmPRNResult of Extraordinary General Meeting
8th Aug 20254:03 pmPRNWeekly Estimate Net Asset Value - August 2025
6th Aug 20257:00 amPRNMonthly Update: July 2025 NAV Performance
4th Aug 20252:10 pmPRNMonthly Estimate Net Asset Value - July 2025
1st Aug 20256:25 pmPRNWeekly Estimate Net Asset Value - July 2025
1st Aug 20252:44 pmPRNMonthly Final Net Asset Value - June 2025
25th Jul 20254:45 pmPRNWeekly Estimate Net Asset Value - July 2025
25th Jul 20254:11 pmPRNPosting of Circular and notice of extraordinary general meeting
25th Jul 20254:10 pmPRNNotice of Annual General Meeting
23rd Jul 20252:23 pmPRNUpdate on proposed recommended acquisition of Malibu Life Reinsurance SPC
18th Jul 20254:23 pmPRNWeekly Estimate Net Asset Value - July 2025
15th Jul 202511:06 amPRNDirector/PDMR Shareholding
11th Jul 20255:44 pmPRNWeekly Estimate Net Asset Value - July 2025
4th Jul 20251:42 pmPRNWeekly Estimate Net Asset Value - July 2025
4th Jul 20257:00 amPRNMonthly Update: June 2025 NAV Performance
2nd Jul 20255:15 pmPRNMonthly Estimate Net Asset Value - June 2025
30th Jun 20254:56 pmPRNMonthly Final Net Asset Value - May 2025
27th Jun 20255:09 pmPRNWeekly Estimate Net Asset Value - June 2025
20th Jun 20254:51 pmPRNWeekly Estimate Net Asset Value - June 2025
13th Jun 20254:55 pmPRNWeekly Estimate Net Asset Value - June 2025
6th Jun 20252:55 pmPRNWeekly Estimate Net Asset Value - June 2025
5th Jun 20257:00 amPRNMonthly Update: May 2025 NAV Performance
3rd Jun 20256:55 pmPRNMonthly Estimate Net Asset Value - May 2025
30th May 20254:05 pmPRNWeekly Estimate Net Asset Value - May 2025
28th May 20254:46 pmPRNMonthly Final Net Asset Value - April 2025
23rd May 20254:08 pmPRNWeekly Estimate Net Asset Value - May 2025
21st May 20257:00 amPRNTPIL Announces Outcome of Strategy Review
16th May 20252:55 pmPRNWeekly Estimate Net Asset Value - May 2025
9th May 20254:03 pmPRNWeekly Estimate Net Asset Value - May 2025
6th May 20257:00 amPRNMonthly Update: April 2025 NAV Performance
2nd May 20255:11 pmPRNMonthly Estimate Net Asset Value - April 2025
2nd May 20257:00 amPRNThird Point Releases Q1 2025 Investor Letter
1st May 20255:34 pmPRNMonthly Final Net Asset Value - March 2025
25th Apr 20253:43 pmPRNWeekly Estimate Net Asset Value - April 2025
17th Apr 20254:36 pmPRNWeekly Estimate Net Asset Value - April 2025
17th Apr 20257:00 amPRNAnnual Report & Audited Financial Statements for the Period Ended 31 December 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.